shutdowns
Bayer-allied NextRNA Therapeutics winds down operations after missing a milestone in their collaboration
NextRNA Therapeutics; Bayer; lncRNA; long non-coding RNA; oncology; biotech wind-down; missed milestone; Massachusetts biotech; seed and Series A funding; Dana-Farber; Carl Novina; 2025 biotech shutdowns
Biotech Industry’s Turbulent Year: Fierce Biotech’s Top 10 Most-Read Stories of 2024
Biotech industry, layoffs, site shutdowns, FDA rejections, M&A deals, J.P. Morgan Healthcare Conference, biopharma trends